Startup and Finance News

Startup and Finance News

Startup and Finance News

Startup

Apr 22, 2026

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

At Health~Holland Global Investor Forum 2026, Mirjam Huizenga, Founder of Myriagon, presented their approach to non-addictive oral analgesics for neuropathic pain. Watch the video to discover how Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment.

Startup

Apr 22, 2026

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

At Health~Holland Global Investor Forum 2026, Mirjam Huizenga, Founder of Myriagon, presented their approach to non-addictive oral analgesics for neuropathic pain. Watch the video to discover how Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment.

Startup

Apr 22, 2026

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

At Health~Holland Global Investor Forum 2026, Mirjam Huizenga, Founder of Myriagon, presented their approach to non-addictive oral analgesics for neuropathic pain. Watch the video to discover how Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment.

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Startup

From Science to Startups: A Conversation with the Head of New Ventures at VIB

Startup

From Science to Startups: A Conversation with the Head of New Ventures at VIB

Startup

From Science to Startups: A Conversation with the Head of New Ventures at VIB

Startup

Nine Start-ups of Global Investor Forum selected to pitch at Innovation for Health 2026

Startup

Nine Start-ups of Global Investor Forum selected to pitch at Innovation for Health 2026

Startup

Nine Start-ups of Global Investor Forum selected to pitch at Innovation for Health 2026

Startup

CeraVx is advancing next-generation drug delivery technologies with its proprietary microneedle drug-delivery platform

Startup

CeraVx is advancing next-generation drug delivery technologies with its proprietary microneedle drug-delivery platform

Startup

CeraVx is advancing next-generation drug delivery technologies with its proprietary microneedle drug-delivery platform

Startup

Wavefront Therapeutics Wins Innovation for Health 2026 Start-up Pitch Contest

Startup

Wavefront Therapeutics Wins Innovation for Health 2026 Start-up Pitch Contest

Startup

Wavefront Therapeutics Wins Innovation for Health 2026 Start-up Pitch Contest

Startup

Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

Startup

Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

Startup

Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

Startup

Scinus Secures €3 Million Strategic Investment to Accelerate Global Roll-Out of the Osilaris™ Cell Expansion Platform

Startup

Scinus Secures €3 Million Strategic Investment to Accelerate Global Roll-Out of the Osilaris™ Cell Expansion Platform

Startup

Scinus Secures €3 Million Strategic Investment to Accelerate Global Roll-Out of the Osilaris™ Cell Expansion Platform

Load More Startup News

Featured

MORE

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Partnerships

Oncode Accelerator Supports International Collaboration to Develop Novel Neuroblastoma Therapy

Partnerships

Oncode Accelerator Supports International Collaboration to Develop Novel Neuroblastoma Therapy

Startup

Where you live should not determine whether your cancer is found in time

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Industry

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Advertisement

Advertisement